CD8A and neoplasm: In addition, baseline CD8+ T-cell infiltration or baseline IFNγ signature were not associated with the response to the combination therapy, suggesting that locoregional virotherapy may overcome primary resistance to ICI therapy by modulating the tumor immune microenvironment.